Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis
Abstract Background Escitalopram is selective serotonin reuptake inhibitors (SSRIs) and one of the most commonly prescribed newer antidepressants (ADs) worldwide. We aimed to explore the efficacy, acceptability and tolerability of escitalopram in comparison with other ADs in the acute-phase treatmen...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2023-11-01
|
| Cyfres: | BMC Psychiatry |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s12888-023-05382-8 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|